Rigel Pharmaceuticals announced that its CFO, Dean Schorno, will participate in three key investor conferences in September 2026, including Citi's Biopharma Back to School, Cantor Global Healthcare, and H.C. Wainwright's Global Investment Conference. The company will hold one-on-one meetings and present overviews of its business, providing updates on its focus in hematologic disorders and cancer therapies. Investors can access live and archived presentations via Rigel's website. This engagement highlights Rigel's efforts to maintain investor relations and showcase its pipeline and marketed products.
Nvidia has returned a record $26 billion to its shareholders after increasing its dividend by an extraordinary 2,400%. This massive payout highlights the company's strong financial position and commitment to rewarding investors. The significant divid...
AGCO introduced the Massey Ferguson N-Series split/narrow row planters at the 2026 Farm Progress Show, featuring factory-installed Precision Planting technology and modular design. These planters come in six configurations, offering farmers flexibili...
In August 2026, US private-sector employment grew by 38,000 jobs, marking the slowest job creation pace since January. Base pay increased by 3.2% and gross pay by 4.7% year-over-year, with job-changers seeing higher wage growth than job-stayers. The ...
Oxford BioMedica's shares fell 15% after Novartis and Bristol Myers Squibb paused enrollment in their autoimmune CAR-T therapy trials due to safety concerns, including patient deaths and inflammatory events. Despite this, broker Panmure Liberum maint...
Goldman Sachs analyzed $10 trillion in equity holdings and found that both hedge funds and mutual funds share strong interest in four large-cap dividend-paying financial stocks: Bank of America, Capital One Financial, Mastercard, and Visa. These comp...
